NCT03990285 - [18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin ) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

November 18, 2021

Study Completion Date

November 18, 2021

Conditions

Glioma Glioblastoma Multiforme

Interventions

DRUG

Axumin, Intravenous Solution

To compare 18F-fluciclovine PET uptake measures in glioblastoma patients with tumor progression versus pseudoprogression

Trial Locations (1)

Hospital of the University of Pennsylvania, Philadelphia